EP3534885
FARNESÝLTRANSFERASA HEMLAR TIL NOTKUNAR VIÐ MEÐFERÐ KRABBAMEINS
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
2.11.2017EP published:
20.1.2021EP application number:
17842428.9
EP translation filed:
7.4.2021Grant published:
15.5.2021EPO information:
European Patent Register
Max expiry date:
1.11.2037Expiry date:
1.11.2023
Title:
FARNESYLTRANSFERASE INHIBITORS FOR USE IN TREATING CANCER
Timeline
Today
2.11.2017EP application
20.1.2021EP Publication
7.4.2021Translation submitted
15.5.2021Registration published
1.11.2023Expires
Owner
Name:
Kura Oncology, Inc.Address:
12730 High Bluff Drive, Suite 400, San Diego, CA 92130, US
Inventor
Name:
GUALBERTO, AntonioAddress:
Acton, MA 01720, US
Name:
SCHOLZ, Catherine RoseAddress:
North Reading, MA 01864, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201662417044 PDate:
3.11.2016Country:
US
Classification
Categories:
A61K 31/4709, A61K 31/00, A61P 35/00, A61P 35/04, C12Q 1/68, C12Q 1/6886
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 7.10.2021
Expires: 1.11.2022
Payer: Árnason Faktor ehf.
Number: 6
Paid: 6.10.2022
Expires: 1.11.2023
Payer: Árnason Faktor ehf.